Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

NCT04835025 · clinicaltrials.gov ↗

SUSPENDED

Status

200

Enrollment

OTHER

Sponsor class

Stopped because of COVID-19

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: PD-1/PD-L1 inhibitor

Sponsor

Tongji Hospital

Collaborators

[object Object]
[object Object]
[object Object]